Hypersensitivity reactions to paclitaxel: The Mexican experience of rapid desensitization.

Rosalaura V Villarreal GonzálezSandra N González DíazRodrigo A de la Cruz CruzOscar Vidal GutiérrezCindy Elizabeth De Lira-Quezada

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

Paclitaxel continues to be a common use drug and has a high rate of adverse drug reactions. This is the first study of hypersensitivity to paclitaxel in a Mexican population.

Keyphrases

adverse drug
drug induced
electronic health record
emergency department
chemotherapy induced